IJAR.2023.213
Type of Article: Original Research
Volume 11; Issue 4 (December 2023)
Page No.: 8752-8760
DOI: https://dx.doi.org/10.16965/ijar.2023.213
Comparison of Calcimycin and Ionomycin-induced Assisted Oocyte Activation in Cases with Male Infertility: A Study of Control Sibling Oocyte
Abdelrhman Saber *1, Mohammed Ahmed Faris 2, Sayed Bakry 1.
*1 Center of Genetic Engineering, Al-Azhar University, Nasr City, Cairo, Egypt. ORCiD: 0009-0009-0553-3096 ORCiD: 0000-0002-6799-5706
2 Department of Obstetrics and Gynecology Faculty of Medicine, Ain Shams University, Cairo, Egypt. ORCiD: 0000-0003-4198-0175
Corresponding author: Dr. Abdelrhman Saber, Center of Genetic Engineering, Al-Azhar University, Nasr City, Cairo, Egypt. E-Mail: abdosaberscience@gmail.com
ABSTRACT
Using control sibling oocytes, the prospective study on the treatment of male infertility factors was conducted in a private IVF center located in Cairo, Egypt. Each case of male factor infertility was treated with both calcimycin and ionomycin, and then the rate of fertilization, cleavage, and quality of embryo were statistically compared. The total number of included cases in the study was n=112. Pregnancy and postpartum follow-up were not investigated. Calcimycin and ionomycin showed nonsignificant T-value in rates of fertilization, cleavage, and good-quality embryos than non-treated embryos. Group I (n=59) treated versus control show fertilization rate of 76.6%, 48.9%, cleavage rate of 95.4%, 85.3%, the good quality embryos 47.1%, 18.5%, respectively. Group II (n=53) treated versus control show fertilization rate of 81.1 %, 50.8%, cleavage rate of 92.5%, 81.4%, the good quality embryos 42%, 29.9%, respectively. The utilization of assisted oocyte activation, ionomycin, and calcimycin has been proposed to possibly increase the number of zygotes, improve cleavage, and create high-quality embryos, boosting the probability of embryo transfer trials.
Key words: Calcimycin, Ionomycin, Male factor infertility, Sibling oocytes.
REFERENCES
[1]. Brezina, P.R. and Y. Zhao, The ethical, legal, and social issues impacted by modern assisted reproductive technologies. 2012. 2012.
[2]. Boulet SL, Mehta A, Kissin DM, Warner L, Kawwass JF, Jamieson DJ. Trends in use of and reproductive outcomes associated with intracytoplasmic sperm injection. JAMA. 2015 Jan 20;313(3):255-63. doi: 10.1001/jama.2014.17985. PMID: 25602996; PMCID: PMC4343214.
[3]. Palermo GD, Neri QV, Takeuchi T, Rosenwaks Z. ICSI: where we have been and where we are going. Semin Reprod Med. 2009 Mar;27(2):191-201. doi: 10.1055/s-0029-1202309. Epub 2009 Feb 26. PMID: 19247922.
[4]. Cardona Barberán A, Boel A, Vanden Meerschaut F, Stoop D, Heindryckx B. SPERM FACTORS AND EGG ACTIVATION: Fertilization failure after human ICSI and the clinical potential of PLCZ1. Reproduction. 2022 May 23;164(1):F39-F51. doi: 10.1530/REP-21-0387. PMID: 35038316.
[5]. Tesarik J, Rienzi L, Ubaldi F, Mendoza C, Greco E. Use of a modified intracytoplasmic sperm injection technique to overcome sperm-borne and oocyte-borne oocyte activation failures. Fertil Steril. 2002 Sep;78(3):619-24. doi: 10.1016/s0015-0282(02)03291-0. PMID: 12215343.
[6]. Kashir J, Heindryckx B, Jones C, De Sutter P, Parrington J, Coward K. Oocyte activation, phospholipase C zeta and human infertility. Hum Reprod Update. 2010 Nov-Dec;16(6):690-703. doi: 10.1093/humupd/dmq018. Epub 2010 Jun 23. PMID: 20573804.
[7]. Yang YR, Follo MY, Cocco L, Suh PG. The physiological roles of primary phospholipase C. Adv Biol Regul. 2013 Sep;53(3):232-41. doi: 10.1016/j.jbior.2013.08.003. Epub 2013 Aug 27. PMID: 24041464.
[8]. Taylor CW, Tovey SC, Rossi AM, Lopez Sanjurjo CI, Prole DL, Rahman T. Structural organization of signalling to and from IP3 receptors. Biochem Soc Trans. 2014 Feb;42(1):63-70. doi: 10.1042/BST20130205. PMID: 24450629.
[9]. Newton, A.C.J.B.J., Tuning the Signaling Output of Protein Kinase C. 2018;114(3):544a.
[10]. Yoon HJ, Bae IH, Kim HJ, Jang JM, Hur YS, Kim HK, Yoon SH, Lee WD, Lim JH. Analysis of clinical outcomes with respect to spermatozoan origin after artificial oocyte activation with a calcium ionophore. J Assist Reprod Genet. 2013 Dec;30(12):1569-75. doi: 10.1007/s10815-013-0110-2. Epub 2013 Oct 10. PMID: 24114629; PMCID: PMC3843179.
[11]. Nomikos M, Yu Y, Elgmati K, Theodoridou M, Campbell K, Vassilakopoulou V, Zikos C, Livaniou E, Amso N, Nounesis G, Swann K, Lai FA. Phospholipase Cζ rescues failed oocyte activation in a prototype of male factor infertility. Fertil Steril. 2013 Jan;99(1):76-85. doi: 10.1016/j.fertnstert.2012.08.035. Epub 2012 Sep 21. PMID: 22999959; PMCID: PMC3540263.
[12]. Vanden Meerschaut F, Nikiforaki D, Heindryckx B, De Sutter P. Assisted oocyte activation following ICSI fertilization failure. Reprod Biomed Online. 2014 May;28(5):560-71. doi: 10.1016/j.rbmo.2014.01.008. Epub 2014 Jan 31. PMID: 24656559.
[13]. WHO, Laboratory manual for the examination of human semen and sperm cervical mucus interaction, ed. 5th. 2010: New York: Cambridge University Press.
[14]. Palermo G, Joris H, Devroey P, Van Steirteghem AC. Pregnancies after intracytoplasmic injection of single spermatozoon into an oocyte. Lancet. 1992 Jul 4;340(8810):17-8. doi: 10.1016/0140-6736(92)92425-f. PMID: 1351601.
[15]. Racowsky C, Vernon M, Mayer J, Ball GD, Behr B, Pomeroy KO, Wininger D, Gibbons W, Conaghan J, Stern JE. Standardization of grading embryo morphology. J Assist Reprod Genet. 2010 Aug;27(8):437-9. doi: 10.1007/s10815-010-9443-2. Epub 2010 Jun 9. PMID: 20532975; PMCID: PMC2941588.
[16]. Bonte D, Ferrer-Buitrago M, Dhaenens L, Popovic M, Thys V, De Croo I, De Gheselle S, Steyaert N, Boel A, Vanden Meerschaut F, De Sutter P, Heindryckx B. Assisted oocyte activation significantly increases fertilization and pregnancy outcome in patients with low and total failed fertilization after intracytoplasmic sperm injection: a 17-year retrospective study. Fertil Steril. 2019 Aug;112(2):266-274. doi: 10.1016/j.fertnstert.2019.04.006. Epub 2019 May 24. PMID: 31133387.
[17]. Li J, Zheng X, Lian Y, Li M, Lin S, Zhuang X, Chen L, Liu P, Qiao J. Artificial oocyte activation improves cycles with prospects of ICSI fertilization failure: a sibling oocyte control study. Reprod Biomed Online. 2019 Aug;39(2):199-204. doi: 10.1016/j.rbmo.2019.03.216. Epub 2019 Apr 5. PMID: 31160240.
[18]. Ebner T, Köster M, Shebl O, Moser M, Van der Ven H, Tews G, Montag M. Application of a ready-to-use calcium ionophore increases rates of fertilization and pregnancy in severe male factor infertility. Fertil Steril. 2012 Dec;98(6):1432-7. doi: 10.1016/j.fertnstert.2012.07.1134. Epub 2012 Aug 24. PMID: 22921909.
[19]. Heindryckx B, De Gheselle S, Gerris J, Dhont M, De Sutter P. Efficiency of assisted oocyte activation as a solution for failed intracytoplasmic sperm injection. Reprod Biomed Online. 2008 Nov;17(5):662-8. doi: 10.1016/s1472-6483(10)60313-6. PMID: 18983750.
[20]. Sfontouris IA, Nastri CO, Lima ML, Tahmasbpourmarzouni E, Raine-Fenning N, Martins WP. Artificial oocyte activation to improve reproductive outcomes in women with previous fertilization failure: a systematic review and meta-analysis of RCTs. Hum Reprod. 2015 Aug;30(8):1831-41. doi: 10.1093/humrep/dev136. Epub 2015 Jun 16. PMID: 26082476.
[21]. Nasr-Esfahani MH, Razavi S, Mardani M, Shirazi R, Javanmardi S. Effects of failed oocyte activation and sperm protamine deficiency on fertilization post-ICSI. Reprod Biomed Online. 2007 Apr;14(4):422-9. doi: 10.1016/s1472-6483(10)60888-7. PMID: 17425821.
[22]. Yoon SY, Jellerette T, Salicioni AM, Lee HC, Yoo MS, Coward K, Parrington J, Grow D, Cibelli JB, Visconti PE, Mager J, Fissore RA. Human sperm devoid of PLC, zeta 1 fail to induce Ca(2+) release and are unable to initiate the first step of embryo development. J Clin Invest. 2008 Nov;118(11):3671-81. doi: 10.1172/JCI36942. Epub 2008 Oct 16. PMID: 18924610; PMCID: PMC2567839.
[23]. Chen J, Qian Y, Tan Y, Mima H. Successful pregnancy following oocyte activation by strontium in normozoospermic patients of unexplained infertility with fertilisation failures during previous intracytoplasmic sperm injection treatment. Reprod Fertil Dev. 2010;22(5):852-5. doi: 10.1071/RD09268. PMID: 20450837.
[24]. Liu Y, Han XJ, Liu MH, Wang SY, Jia CW, Yu L, Ren G, Wang L, Li W. Three-day-old human unfertilized oocytes after in vitro fertilization/intracytoplasmic sperm injection can be activated by calcium ionophore a23187 or strontium chloride and develop to blastocysts. Cell Reprogram. 2014 Aug;16(4):276-80. doi: 10.1089/cell.2013.0081. Epub 2014 Jun 24. PMID: 24960285; PMCID: PMC4116138.
[25]. Fawzy M, Emad M, Mahran A, Sabry M, Fetih AN, Abdelghafar H, Rasheed S. Artificial oocyte activation with SrCl2 or calcimycin after ICSI improves clinical and embryological outcomes compared with ICSI alone: results of a randomized clinical trial. Hum Reprod. 2018 Sep 1;33(9):1636-1644. doi: 10.1093/humrep/dey258. PMID: 30099496.
[26]. Meng X, Melo P, Jones C, Ross C, Mounce G, Turner K, Child T, Coward K. Use of phospholipase C zeta analysis to identify candidates for artificial oocyte activation: a case series of clinical pregnancies and a proposed algorithm for patient management. Fertil Steril. 2020 Jul;114(1):163-174. doi: 10.1016/j.fertnstert.2020.02.113. PMID: 32622408.
[27]. Kashir J. Increasing associations between defects in phospholipase C zeta and conditions of male infertility: not just ICSI failure? J Assist Reprod Genet. 2020 Jun;37(6):1273-1293. doi: 10.1007/s10815-020-01748-z. Epub 2020 Apr 14. PMID: 32285298; PMCID: PMC7311621.
[28]. Nazarian H, Azad N, Nazari L, Piryaei A, Heidari MH, Masteri-Farahani R, Karimi M, Ghaffari-Novin M. Effect of Artificial Oocyte Activation on Intra-Cytoplasmic Sperm Injection Outcomes in Patients with Lower Percentage of Sperm Containing Phospholipase Cζ: A Randomized Clinical Trial. J Reprod Infertil. 2019 Jan-Mar;20(1):3-9. PMID: 30859076; PMCID: PMC6386797.
[29]. Norozi-Hafshejani M, Tavalaee M, Azadi L, Bahadorani M, Nasr-Esfahani MH. Effects of assisted oocyte activation with calcium- ionophore and strontium chloride on in vitro ICSI outcomes. Iran J Basic Med Sci. 2018 Nov;21(11):1109-1117. doi: 10.22038/IJBMS.2018.30422.7331. PMID: 30483383; PMCID: PMC6251390.
[30]. Jia L, Chen P, Su W, He S, Guo Y, Zheng L, Fang C, Liang X. Artificial oocyte activation with ionomycin compared with A23187 among patients at risk of failed or impaired fertilization. Reprod Biomed Online. 2023 Jan;46(1):35-45. doi: 10.1016/j.rbmo.2022.08.105. Epub 2022 Aug 25. PMID: 36379856.
[31]. Shan Y, Zhao H, Zhao D, Wang J, Cui Y, Bao H. Assisted Oocyte Activation With Calcium Ionophore Improves Pregnancy Outcomes and Offspring Safety in Infertile Patients: A Systematic Review and Meta-Analysis. Front Physiol. 2022 Jan 24;12:751905. doi: 10.3389/fphys.2021.751905. PMID: 35140624; PMCID: PMC8819094.
[32]. Sughashini Murugesu, Srdjan Saso, Benjamin P. Jones, Timothy Bracewell-Milnes, Thanos Athanasiou, Anastasia Mania, Paul Serhal, Jara Ben-Nagi. Does the use of calcium ionophore during artificial oocyte activation demonstrate an effect on pregnancy rate? A meta-analysis. Fertility and Sterility, 2017;108(3):468-482.e3.
[33]. Aydinuraz B, Dirican EK, Olgan S, Aksunger O, Erturk OK. Artificial oocyte activation after intracytoplasmic morphologically selected sperm injection: A prospective randomized sibling oocyte study. Hum Fertil (Camb). 2016 Dec;19(4):282-288. doi: 10.1080/14647273.2016.1240374. Epub 2016 Oct 13. PMID: 27734719.
[34]. Eftekhar M, Janati S, Rahsepar M, Aflatoonian A. Effect of oocyte activation with calcium ionophore on ICSI outcomes in teratospermia: A randomized clinical trial. Iran J Reprod Med. 2013 Nov;11(11):875-82. PMID: 24639711; PMCID: PMC3941389.
[35]. Cardona Barberán A, Bonte D, Boel A, Thys V, Paredis R, Machtelinckx F, De Sutter P, De Croo I, Leybaert L, Stoop D, Coucke P, Vanden Meerschaut F, Heindryckx B. Assisted oocyte activation does not overcome recurrent embryo developmental problems. Hum Reprod. 2023 May 2;38(5):872-885. doi: 10.1093/humrep/dead051. PMID: 36931261.
[36]. Norozi-Hafshejani M, Tavalaee M, Azadi L, Bahadorani M, Nasr-Esfahani MH. Effects of assisted oocyte activation with calcium- ionophore and strontium chloride on in vitro ICSI outcomes. Iran J Basic Med Sci. 2018 Nov;21(11):1109-1117. doi: 10.22038/IJBMS.2018.30422.7331. PMID: 30483383; PMCID: PMC6251390.
[37]. Yeste M, Jones C, Amdani SN, Patel S, Coward K. Oocyte activation deficiency: a role for an oocyte contribution? Hum Reprod Update. 2016 Jan-Feb;22(1):23-47. doi: 10.1093/humupd/dmv040. Epub 2015 Sep 7. PMID: 26346057.
[38]. Netanella Miller, Tal Biron-Shental, Rivka Sukenik-Halevy, Anat Hershko Klement, Reuven Sharony, Arie Berkovitz. Oocyte activation by calcium ionophore and congenital birth defects: a retrospective cohort study. Fertility and Sterility, 2016;106(3):590-596.e2.
[39]. Li B, Zhou Y, Yan Z, Li M, Xue S, Cai R, Fu Y, Hong Q, Long H, Yin M, Du T, Wang Y, Kuang Y, Yan Z, Lyu Q. Pregnancy and neonatal outcomes of artificial oocyte activation in patients undergoing frozen-thawed embryo transfer: a 6-year population-based retrospective study. Arch Gynecol Obstet. 2019 Oct;300(4):1083-1092. doi: 10.1007/s00404-019-05298-3. Epub 2019 Sep 16. PMID: 31529366.
[40]. Deemeh MR, Tavalaee M, Nasr-Esfahani MH. Health of children born through artificial oocyte activation: a pilot study. Reprod Sci. 2015 Mar;22(3):322-8. doi: 10.1177/1933719114542017. Epub 2014 Jul 15. PMID: 25028175.
[41]. Ferrer-Buitrago M, Dhaenens L, Lu Y, Bonte D, Vanden Meerschaut F, De Sutter P, Leybaert L, Heindryckx B. Human oocyte calcium analysis predicts the response to assisted oocyte activation in patients experiencing fertilization failure after ICSI. Hum Reprod. 2018 Mar 1;33(3):416-425. doi: 10.1093/humrep/dex376. PMID: 29329390.
